Last Updated: November 8, 2026

Wockhardt Usa Company Profile

« Back to Dashboard


What is the competitive landscape for WOCKHARDT USA

WOCKHARDT USA has six approved drugs.



Summary for Wockhardt Usa
US Patents:0
Tradenames:4
Ingredients:3
NDAs:6
Patent Litigation for Wockhardt Usa: See patent lawsuits for Wockhardt Usa

Drugs and US Patents for Wockhardt Usa

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt Usa OCTREOTIDE ACETATE PRESERVATIVE FREE octreotide acetate INJECTABLE;INJECTION 090985-001 May 11, 2011 DISCN No No ⤷  Start Trial ⤷  Start Trial
Wockhardt Usa GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 078564-001 Jun 30, 2008 DISCN No No ⤷  Start Trial ⤷  Start Trial
Wockhardt Usa OCTREOTIDE ACETATE PRESERVATIVE FREE octreotide acetate INJECTABLE;INJECTION 090985-003 May 11, 2011 DISCN No No ⤷  Start Trial ⤷  Start Trial
Wockhardt Usa OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 090986-001 May 11, 2011 DISCN No No ⤷  Start Trial ⤷  Start Trial
Wockhardt Usa OCTREOTIDE ACETATE PRESERVATIVE FREE octreotide acetate INJECTABLE;INJECTION 090985-002 May 11, 2011 DISCN No No ⤷  Start Trial ⤷  Start Trial
Wockhardt Usa GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 078566-001 Feb 29, 2008 DISCN No No ⤷  Start Trial ⤷  Start Trial
Wockhardt Usa OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 090986-002 May 11, 2011 DISCN No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links